Literature DB >> 3948368

Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations.

B G Brown, C A Gallery, R S Badger, J W Kennedy, D Mathey, E L Bolson, H T Dodge.   

Abstract

Thrombolytic recanalization of the obstructed coronary lumen was studied in 32 patients receiving intracoronary streptokinase for 60 to 90 min during acute myocardial infarction. The process was viewed at high arteriographic magnification and was quantified with computer-assisted measurements from repeated single-plane views. The variability of the method for this application was 0.15 to 0.18 mm on minimum diameter estimates. Structural details were seen that are not commonly appreciated at conventional magnification. The recanalized lumen appears to form along an interface between the thrombus and the vessel wall, progressively enlarging its minimum arteriographic diameter to 0.65 +/- 0.24 mm (+/- 1 SD) at the end of the short-term infusion of streptokinase reflecting a final percent stenosis of 77 +/- 10%. In nine infarct lesions found patent 5 +/- 3 weeks later, the recanalized lumen further improved an average of 0.34 mm in minimum diameter (p less than .005) and 13% stenosis (p less than .01). A thin film of contrast medium surrounding the obstructing thrombus faintly defined the boundaries of the original atherosclerotic lumen in all but two cases. The "original stenosis" measured 1.25 +/- 0.32 mm in minimum diameter and 56 +/- 14% stenosis when first visualized; it was unchanged throughout the course of infusion of streptokinase. In five patients catheterized 10 +/- 12 weeks before their infarction, the original stenosis averaged 1.15 +/- 0.22 mm in the preinfarct angiogram, as compared with 1.17 +/- 0.23 mm in its faintly defined form during thrombolytic therapy (p = NS). In 10 cases, this original lesion was less than a 50% stenosis, and in 21 cases less than 60%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3948368     DOI: 10.1161/01.cir.73.4.653

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  24 in total

1.  Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  Comparison of digital and cine coronary arteriography.

Authors:  J C Gurley; S E Nissen
Journal:  Int J Card Imaging       Date:  1990

Review 3.  Arterial thrombosis--insidious, unpredictable and deadly.

Authors:  Shaun P Jackson
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 4.  Successful and unsuccessful coronary thrombolysis.

Authors:  M J Davies
Journal:  Br Heart J       Date:  1989-05

5.  Does psychological stress contribute to the development of hypertension and coronary heart disease?

Authors:  T G Pickering
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Time-course of dobutamine-induced wall motion abnormalities in the infarct area following thrombolytic therapy.

Authors:  R Bigi; G Curti; C Sponzilli; D Castini; G Occhi; C Fiorentini
Journal:  Int J Card Imaging       Date:  1998-12

Review 7.  Vessel wall-related risk factors in acute vascular events.

Authors:  L Badimon; J J Badimon; M Cohen; J H Chesebro; V Fuster
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 8.  A new look at coronary angiograms: plaque morphology as a help to diagnosis and to evaluate outcome.

Authors:  J Lespérance; P Théroux; G Hudon; D Waters
Journal:  Int J Card Imaging       Date:  1994-06

9.  Early remodelling of coronary stenoses after thrombolytic treatment in patients with acute myocardial infarction.

Authors:  D Tousoulis; F Andreotti; D Hackett; A W Haider; A Maseri; G Davies
Journal:  Br Heart J       Date:  1995-09

10.  Prognostic significance of transient myocardial ischaemia after first acute myocardial infarction: five year follow up study.

Authors:  H Mickley; J R Nielsen; J Berning; A Junker; M Møller
Journal:  Br Heart J       Date:  1995-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.